Evaluating Cost Savings Associated with a Patient-Facing Asthma Mobile Health Intervention
Applied Clinical Informatics · 01.08.2025 · 16 (04) · 1086-1094
DOI: 10.1055/a-2595-3329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Clinical Informatics, erschienen am 01.08.2025. Verfasst von Julia Nadelmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Bronx, New York, United States. Hauptthemen laut MEDLINE: Asthma, Cost Savings, Telemedicine. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The patient-facing ASTHMAXcel mobile platform has been linked to improved asthma knowledge decreased asthma-related health care utilization (emergency department [ED] visits, hospitalizations), and reduced prednisone use among adult and pediatric patient populations. Given the upfront costs associated with developing mobile health platforms, this paper seeks to estimate the savings attributable to pediatric and adult users of the ASTHMAXcel platform through decreased hospitalizations, ED visits, and prednisone use. Forty adult patients and 39 pediatric patients with asthma completed studies evaluating the effectiveness of the ASTHMAXcel mobile platform at Montefiore Medical Center. Study participants received the mobile intervention for 6 months and questionnaires were administered at baseline and follow-up visits. Using internal cost data from Montefiore and information on insurance coverage, we estimated the average costs saved by the decreases in ED visits, hospitalizations, and prednisone usage throughout the study time period. Throughout the study time period, participant exposure to ASTHMAXcel and ASTHMAXcel adventures was estimated to save a total of $367,280 with $270,732 in savings from adults' decreased asthma-related health care utilization and $96,548 from pediatric decreases in asthma-related health care utilization. The bulk of these savings estimates are driven by decreases in hospitalizations among both pediatric and adult participants during the study time frame. Given the significant economic burden of asthma treatment and management and its disproportionate impact on those who are economically disadvantaged, it is critical that asthma interventions are assessed not only for their clinical effectiveness but also for their cost-effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Albert Einstein College of Medicine, Bronx, New York, United States.
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Department of Psychiatry, McGaw Medical Center of Northwestern, Chicago, Illinois, United States.
- Department of Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States.
- Department of Allergy and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States.
Zitieren
APA
Nadelmann, J., Patel, M., Lane, S., Hammock, J., Stark, A., & Jariwala, S. P. (2025). Evaluating Cost Savings Associated with a Patient-Facing Asthma Mobile Health Intervention. Applied Clinical Informatics, 16(04), 1086-1094. https://doi.org/10.1055/a-2595-3329
Vancouver
Nadelmann J, Patel M, Lane S, Hammock J, Stark A, Jariwala SP. Evaluating Cost Savings Associated with a Patient-Facing Asthma Mobile Health Intervention. Applied Clinical Informatics. 2025;16(04):1086-1094. doi:10.1055/a-2595-3329
BibTeX
@article{Nadelmann2025,
author = {Nadelmann, Julia and Patel, Milin and Lane, Sarah and Hammock, James and Stark, Allison and Jariwala, Sunit P},
title = {Evaluating Cost Savings Associated with a Patient-Facing Asthma Mobile Health Intervention},
journal = {Applied Clinical Informatics},
year = {2025},
volume = {16},
number = {04},
pages = {1086--1094},
doi = {10.1055/a-2595-3329}
}
EUVIMED